BioWorld

Nov. 15, 2005

Viventia Merging, Becoming Private: C$12M To Pay Debt

PDUFA Being Reviewed Prior To Reauthorization

Speedel Presents Confirmatory Positive SPP301 Phase II Data

Other News To Note

OSI, Eyetech Close Merger After Look At Lucentis Data

Although it had to work on the weekend to calm any fears, OSI Pharmaceuticals Inc. closed its merger with Eyetech Pharmaceuticals Inc. Monday - much to the chagrin of some OSI analysts and investors. (BioWorld Today) Read More

Today's news in brief

BioWorld

BioWorld briefs for Jan 26, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 23, 2026.

Illustration of magnifying glass inspecting brain

Neurotrimin unveiled as marker in intellectual disability

BioWorld Science

Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...